SCHEMBL32665196

SCHEMBL32665196

NCCc1cccc(S(=O)(=O)F)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.67
F2 P00734 2/20 0.61
TMPRSS4 Q9NRS4 2/20 0.61
TP53 P04637 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2D6 P10635 1/20 0.61
TSHR P16473 1/20 0.61
TAAR1 Q96RJ0 8/20 0.53
DRD2 P14416 1/20 0.48
DRD1 P21728 1/20 0.48
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA6 P23280 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
CA5B Q9Y2D0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3190954 0.85 HTR6 (0.51) HTR6F2TMPRSS4TP53CYP1A2
Hydrochloric Acid SCHEMBL21199322 0.83 HTR6 (0.50) HTR6F2TMPRSS4TP53CYP1A2
SCHEMBL3735049 0.83 HTR6 (0.69) HTR6TAAR1DRD2DRD1CA12
SCHEMBL30839505 0.83 HTR6 (0.69) HTR6TAAR1DRD2DRD1CA12
SCHEMBL2204086 0.81 HTR6 (0.67) HTR6TAAR1DRD2DRD1CA12
SCHEMBL10034885 0.81 HTR6 (0.67) HTR6F2TMPRSS4TP53CYP1A2
Hydrochloric Acid SCHEMBL15741790 0.80 HTR6 (0.65) HTR6F2TMPRSS4TAAR1DRD2
SCHEMBL23665676 0.77 ALDH1A1 (0.43) HTR6CYP1A2CA2
SCHEMBL17315295 0.77 HTR6 (0.61) HTR6F2TMPRSS4TP53CYP1A2
SCHEMBL11207039 0.77 NPC1 (0.42) HTR6F2TMPRSS4TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A HTR6 4206/4885F2 3542/4885TMPRSS4 2353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.